Section Arrow
Quote
BCYC.NASDAQ
- Bicycle Therapeutics plc
Quotes are at least 15-min delayed:2025/01/12 03:48 EST
Last
 13.31
-0.86 (-6.07%)
Day High 
13.9892 
Prev. Close
14.17 
1-M High
21.5013 
Volume 
300.36K 
Bid
13.29
Ask
14.73
Day Low
13.2 
Open
13.98 
1-M Low
12.17 
Market Cap 
978.38M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.54 
20-SMA 15.55 
50-SMA 19.37 
52-W High 28.670102 
52-W Low 12.17 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.28/-3.47
Enterprise Value
1.02B
Balance Sheet
Book Value Per Share
12.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
26.98M
Operating Revenue Per Share
0.36
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed：2025/01/12 03:48 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.